Guyasuta Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58M | Buy |
115,679
+911
| +0.8% | +$437K | 3% | 9 |
|
|
2026
Q1 | $56.4M | Buy |
114,768
+770
| +0.7% | +$418K | 3.26% | 7 |
|
|
2025
Q4 | $66.1M | Buy |
113,998
+2,559
| +2% | +$1.45M | 3.77% | 7 |
|
|
2025
Q3 | $54.1M | Buy |
111,439
+1,524
| +1% | +$709K | 3.11% | 8 |
|
|
2025
Q2 | $44.6M | Buy |
109,915
+5,836
| +6% | +$2.44M | 2.73% | 9 |
|
|
2025
Q1 | $51.8M | Sell |
104,079
-1,585
| -2% | -$858K | 3.39% | 7 |
|
|
2024
Q4 | $55M | Buy |
105,664
+1,821
| +2% | +$1M | 3.46% | 7 |
|
|
2024
Q3 | $64.2M | Buy |
103,843
+1,026
| +1% | +$607K | 3.96% | 6 |
|
|
2024
Q2 | $54.6M | Sell |
102,817
-2,075
| -2% | -$1.19M | 4.01% | 5 |
|
|
2024
Q1 | $55.7M | Sell |
104,892
-591
| -0.6% | -$332K | 4.04% | 5 |
|
|
2023
Q4 | $56M | Buy |
105,483
+820
| +0.8% | +$397K | 4.05% | 5 |
|
|
2023
Q3 | $53M | Buy |
104,663
+291
| +0.3% | +$155K | 4.1% | 4 |
|
|
2023
Q2 | $54.5M | Sell |
104,372
-725
| -0.7% | -$391K | 4.03% | 4 |
|
|
2023
Q1 | $60.6M | Sell |
105,097
-768
| -0.7% | -$433K | 4.68% | 2 |
|
|
2022
Q4 | $58.3M | Buy |
105,865
+778
| +0.7% | +$412K | 4.6% | 2 |
|
|
2022
Q3 | $53.3M | Buy |
105,087
+197
| +0.2% | +$110K | 4.61% | 3 |
|
|
2022
Q2 | $57M | Buy |
104,890
+582
| +0.6% | +$320K | 4.46% | 2 |
|
|
2022
Q1 | $61.6M | Sell |
104,308
-156
| -0.1% | -$89.6K | 4.23% | 2 |
|
|
2021
Q4 | $69.7M | Sell |
104,464
-866
| -0.8% | -$541K | 4.57% | 2 |
|
|
2021
Q3 | $60.2M | Sell |
105,330
-471
| -0.4% | -$259K | 4.29% | 2 |
|
|
2021
Q2 | $53.4M | Buy |
105,801
+1,082
| +1% | +$511K | 3.84% | 3 |
|
|
2021
Q1 | $47.8M | Sell |
104,719
-2,119
| -2% | -$1.01M | 3.73% | 3 |
|
|
2020
Q4 | $49.8M | Sell |
106,838
-5,986
| -5% | -$2.81M | 4.16% | 3 |
|
|
2020
Q3 | $49.8M | Sell |
112,824
-3,706
| -3% | -$1.53M | 4.63% | 3 |
|
|
2020
Q2 | $42.2M | Sell |
116,530
-522
| -0.4% | -$175K | 4.33% | 3 |
|
|
2020
Q1 | $33.2M | Sell |
117,052
-1,154
| -1% | -$364K | 3.98% | 4 |
|
|
2019
Q4 | $38.4M | Sell |
118,206
-1,533
| -1% | -$465K | 3.73% | 4 |
|
|
2019
Q3 | $34.9M | Buy |
119,739
+303
| +0.3% | +$86.8K | 3.61% | 6 |
|
|
2019
Q2 | $35.1M | Buy |
119,436
+2,132
| +2% | +$587K | 3.64% | 5 |
|
|
2019
Q1 | $32.1M | Sell |
117,304
-1,859
| -2% | -$463K | 3.58% | 7 |
|
|
2018
Q4 | $26.7M | Buy |
119,163
+1,429
| +1% | +$335K | 3.29% | 7 |
|
|
2018
Q3 | $28.7M | Sell |
117,734
-1,577
| -1% | -$363K | 3.06% | 8 |
|
|
2018
Q2 | $24.7M | Sell |
119,311
-593
| -0.5% | -$126K | 2.83% | 12 |
|
|
2018
Q1 | $24.8M | Sell |
119,904
-2,764
| -2% | -$580K | 2.9% | 11 |
|
|
2017
Q4 | $23.3M | Sell |
122,668
-432
| -0.4% | -$82.8K | 2.64% | 13 |
|
|
2017
Q3 | $23.3M | Sell |
123,100
-1,102
| -0.9% | -$200K | 2.81% | 12 |
|
|
2017
Q2 | $21.7M | Sell |
124,202
-971
| -0.8% | -$163K | 2.61% | 15 |
|
|
2017
Q1 | $19.2M | Buy |
125,173
+1,110
| +0.9% | +$170K | 2.32% | 20 |
|
|
2016
Q4 | $17.5M | Buy |
124,063
+4,036
| +3% | +$595K | 2.26% | 20 |
|
|
2016
Q3 | $19.1M | Buy |
120,027
+2,529
| +2% | +$390K | 2.44% | 18 |
|
|
2016
Q2 | $17.4M | Buy |
117,498
+521
| +0.4% | +$76.9K | 2.32% | 20 |
|
|
2016
Q1 | $16.6M | Buy |
116,977
+14,915
| +15% | +$2M | 2.3% | 21 |
|
|
2015
Q4 | $14.5M | Buy |
102,062
+1,098
| +1% | +$146K | 2.04% | 23 |
|
|
2015
Q3 | $12.3M | Buy |
100,964
+486
| +0.5% | +$63.3K | 1.8% | 27 |
|
|
2015
Q2 | $13M | Buy |
100,478
+1,285
| +1% | +$168K | 1.73% | 27 |
|
|
2015
Q1 | $13.3M | Buy |
+99,193
| New | +$12.8M | 1.79% | 27 |
|
Other funds holding TMO
RG
ECSS
LT
Guyasuta Investment Advisors's TMO Position: Q2 2026 in Review
Guyasuta Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 0.79% in Q2 2026, buying an estimated $437K and bringing the position to 115,679 shares worth $58M. The position accounts for 3% of the portfolio, ranked #9.
Guyasuta Investment Advisors first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $69.7M in Q4 2021. 1,118 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Guyasuta Investment Advisors held 115,679 shares of Thermo Fisher Scientific worth $58M as of Q2 2026.
- Guyasuta Investment Advisors bought 911 Thermo Fisher Scientific shares in Q2 2026, an estimated $437K.
- Thermo Fisher Scientific made up 3% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #9 holding.
- Guyasuta Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
- Guyasuta Investment Advisors's Thermo Fisher Scientific position peaked at $69.7M in Q4 2021.
- 1,118 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.